| Dr Duncan Hanby, MD | |
|
10310 The Grove Blvd, Baton Rouge, LA 70836-6455 | |
| (225) 761-5200 | |
| Not Available |
| Full Name | Dr Duncan Hanby |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 18 Years |
| Location | 10310 The Grove Blvd, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346430816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | MD.200929 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
The Palestinian Health Ministry is facing a growing financial crisis as well as a humanitarian crisis, the World Health Organization (WHO) warned ahead of the Stockholm donor conference on the humanitarian situation in the West Bank and Gaza Strip.
Women with obesity have a range of increased health risks in pregnancy, both for them and their babies, compared with those in the healthy weight category, according to a new systematic review of research by academics at the School of Nursing and Midwifery, Trinity College Dublin, the University of Gothenberg, and City University London.
Synageva BioPharma Corp., a privately held biopharmaceutical company, today announced its filing with the U.S. Food and Drug Administration (FDA) requesting orphan drug designation for its program, SBC-102. This program is an enzyme replacement therapy in preclinical development to treat lysosomal acid lipase (LAL) deficiency, also known as Wolman disease or cholesteryl ester storage disease (CESD), a condition for which there is currently no effective treatment.
According to the article, in the United States, the percentage of deceased kidney donors aged 55 and older has increased during the last decade. This is the result of both lower death rates (particularly from trauma) in people aged 18 to 35, and an increased acceptance of kidneys from older deceased donors.
› Verified 9 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
The Palestinian Health Ministry is facing a growing financial crisis as well as a humanitarian crisis, the World Health Organization (WHO) warned ahead of the Stockholm donor conference on the humanitarian situation in the West Bank and Gaza Strip.
Women with obesity have a range of increased health risks in pregnancy, both for them and their babies, compared with those in the healthy weight category, according to a new systematic review of research by academics at the School of Nursing and Midwifery, Trinity College Dublin, the University of Gothenberg, and City University London.
Synageva BioPharma Corp., a privately held biopharmaceutical company, today announced its filing with the U.S. Food and Drug Administration (FDA) requesting orphan drug designation for its program, SBC-102. This program is an enzyme replacement therapy in preclinical development to treat lysosomal acid lipase (LAL) deficiency, also known as Wolman disease or cholesteryl ester storage disease (CESD), a condition for which there is currently no effective treatment.
According to the article, in the United States, the percentage of deceased kidney donors aged 55 and older has increased during the last decade. This is the result of both lower death rates (particularly from trauma) in people aged 18 to 35, and an increased acceptance of kidneys from older deceased donors.
› Verified 9 days ago
| Entity Name | Lsuhn Billing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992975775 PECOS PAC ID: 0446337802 Enrollment ID: O20080409000372 |
News Archive
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
The Palestinian Health Ministry is facing a growing financial crisis as well as a humanitarian crisis, the World Health Organization (WHO) warned ahead of the Stockholm donor conference on the humanitarian situation in the West Bank and Gaza Strip.
Women with obesity have a range of increased health risks in pregnancy, both for them and their babies, compared with those in the healthy weight category, according to a new systematic review of research by academics at the School of Nursing and Midwifery, Trinity College Dublin, the University of Gothenberg, and City University London.
Synageva BioPharma Corp., a privately held biopharmaceutical company, today announced its filing with the U.S. Food and Drug Administration (FDA) requesting orphan drug designation for its program, SBC-102. This program is an enzyme replacement therapy in preclinical development to treat lysosomal acid lipase (LAL) deficiency, also known as Wolman disease or cholesteryl ester storage disease (CESD), a condition for which there is currently no effective treatment.
According to the article, in the United States, the percentage of deceased kidney donors aged 55 and older has increased during the last decade. This is the result of both lower death rates (particularly from trauma) in people aged 18 to 35, and an increased acceptance of kidneys from older deceased donors.
› Verified 9 days ago
| Entity Name | Noel & Hanby Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922361260 PECOS PAC ID: 4880848290 Enrollment ID: O20130213000173 |
News Archive
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
The Palestinian Health Ministry is facing a growing financial crisis as well as a humanitarian crisis, the World Health Organization (WHO) warned ahead of the Stockholm donor conference on the humanitarian situation in the West Bank and Gaza Strip.
Women with obesity have a range of increased health risks in pregnancy, both for them and their babies, compared with those in the healthy weight category, according to a new systematic review of research by academics at the School of Nursing and Midwifery, Trinity College Dublin, the University of Gothenberg, and City University London.
Synageva BioPharma Corp., a privately held biopharmaceutical company, today announced its filing with the U.S. Food and Drug Administration (FDA) requesting orphan drug designation for its program, SBC-102. This program is an enzyme replacement therapy in preclinical development to treat lysosomal acid lipase (LAL) deficiency, also known as Wolman disease or cholesteryl ester storage disease (CESD), a condition for which there is currently no effective treatment.
According to the article, in the United States, the percentage of deceased kidney donors aged 55 and older has increased during the last decade. This is the result of both lower death rates (particularly from trauma) in people aged 18 to 35, and an increased acceptance of kidneys from older deceased donors.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Duncan Hanby, MD 10310 The Grove Blvd, Baton Rouge, LA 70836-6455 Ph: (225) 761-5200 | Dr Duncan Hanby, MD 10310 The Grove Blvd, Baton Rouge, LA 70836-6455 Ph: (225) 761-5200 |
News Archive
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
The Palestinian Health Ministry is facing a growing financial crisis as well as a humanitarian crisis, the World Health Organization (WHO) warned ahead of the Stockholm donor conference on the humanitarian situation in the West Bank and Gaza Strip.
Women with obesity have a range of increased health risks in pregnancy, both for them and their babies, compared with those in the healthy weight category, according to a new systematic review of research by academics at the School of Nursing and Midwifery, Trinity College Dublin, the University of Gothenberg, and City University London.
Synageva BioPharma Corp., a privately held biopharmaceutical company, today announced its filing with the U.S. Food and Drug Administration (FDA) requesting orphan drug designation for its program, SBC-102. This program is an enzyme replacement therapy in preclinical development to treat lysosomal acid lipase (LAL) deficiency, also known as Wolman disease or cholesteryl ester storage disease (CESD), a condition for which there is currently no effective treatment.
According to the article, in the United States, the percentage of deceased kidney donors aged 55 and older has increased during the last decade. This is the result of both lower death rates (particularly from trauma) in people aged 18 to 35, and an increased acceptance of kidneys from older deceased donors.
› Verified 9 days ago
Stanley E. Peters, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd, Ste. 2121, Baton Rouge, LA 70810 Phone: 225-767-7200 Fax: 225-767-7386 | |
Samuel Ralph Barber, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 7777 Hennessy Blvd Ste 709, Baton Rouge, LA 70808 Phone: 225-765-7735 Fax: 225-765-9937 | |
Collin Blake Sutton, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd Ste 2222, Baton Rouge, LA 70810 Phone: 225-408-6900 | |
Dr. Christian A. Hall, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8585 Picardy Ave, Ste 512, Baton Rouge, LA 70809 Phone: 225-819-1181 Fax: 225-636-5900 | |
Dr. Frank L. Fazio, M.D., F.A.C.S. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd Ste 2222, Baton Rouge, LA 70810 Phone: 225-769-2222 Fax: 225-766-2068 | |
Dr. Warner Lee Bruner Iii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 710 Colonial Dr, Baton Rouge, LA 70806 Phone: 225-927-5325 Fax: 225-927-4150 | |
Anna Maria Pou, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4950 Essen Ln, Mbperkins, 4th Floor, Suite A, Baton Rouge, LA 70809 Phone: 225-765-1765 Fax: 225-765-1768 |